Healthcare Fraud: Individual Liability for Executives and High-Level Employees

Identifying and Addressing Risks for Executives; Avoiding OIG Exclusion Sanctions

Recording of a 90-minute CLE webinar with Q&A

This program is included with the Strafford CLE Pass. Click for more information.
This program is included with the Strafford All-Access Pass. Click for more information.

Conducted on Thursday, March 22, 2012

Recorded event now available

or call 1-800-926-7926
Course Materials

This CLE course will offer healthcare counsel guidance on how healthcare companies can protect their executives from government exclusion, identify and address the potential pitfalls in the government's civil investigative demands, and develop effective corporate compliance programs.


The federal government has stepped up efforts to enforce healthcare fraud regulations. To emphasize the importance of compliance, the government has given notice that it will use its administrative authority to exclude corporate executives from federal healthcare programs in certain cases.

In fact, the government recently announced the proposed ban of a healthcare executive of a company that allegedly committed healthcare fraud, even though the executive was not personally involved in any criminal conduct.

Though the ban was withdrawn, it is clear the government will not hesitate to use this draconian tool against healthcare executives. Counsel to healthcare businesses should take proactive steps now to ensure strict compliance with federal healthcare fraud regulations.

Listen as our authoritative panel of healthcare attorneys examines what healthcare companies can do to protect their executives from exclusion, identify the hidden dangers behind civil investigative demands and how to address them, defend executives from exclusion, and review effective corporate compliance.



  1. Lessons learned from recent government healthcare fraud investigations and settlements
  2. Individual liability for corporate executives and high-level employees
    1. Factors when deciding whether to exclude executives
    2. Hidden dangers in government civil investigative demands
  3. Defending executives from OIG exclusion
  4. Corporate healthcare fraud compliance


The panel will review these and other key questions:

  • What lessons can be learned from recent investigations and settlements?
  • What hidden dangers are lurking in the government's civil investigative demands that may directly threaten healthcare companies and executives?
  • What steps can healthcare counsel take to protect executives from government program exclusion?

Following the speaker presentations, you'll have an opportunity to get answers to your specific questions during the interactive Q&A.


Thomas E. Zeno
Thomas E. Zeno

Of Counsel
Squire Sanders

He has more than 25 years of experience in the Fraud and Public Corruption Section of the US Attorney’s Office...  |  Read More

Kimberly J. Donovan
Kimberly J. Donovan

Senior Associate
Squire Sanders

She has experience litigating a variety of issues related to health law, real estate development, complicated real...  |  Read More

Elizabeth E. Trende
Elizabeth E. Trende

Squire Sanders

She advises healthcare providers navigate the changing landscape of healthcare reform. Her practice also includes...  |  Read More

Access Anytime, Anywhere

Strafford will process CLE credit for one person on each recording. All formats include course handouts.

To find out which recorded format will provide the best CLE option, select your state:

CLE On-Demand Audio